Tezacaftor for the treatment of cystic fibrosis

Medicine and Dentistry

• Cystic Fibrosis 100%
• Tezacaftor 100%
• Diseases 50%
• Clinical Trial 50%
• Adverse Event 25%
• Patient with Cystic Fibrosis 25%
• In Vitro 25%
• Ivacaftor 25%
• Targeted Therapy 25%
• Autosomal Recessive Disorder 25%
• Ion Channel 25%
• Combination Drug 25%

Pharmacology, Toxicology and Pharmaceutical Science

• Cystic Fibrosis 100%
• Tezacaftor 100%
• Clinical Trial 40%
• Disease 40%
• Adverse Event 20%
• Autosomal Recessive Disorder 20%
• Ivacaftor 20%
• Ion Channel 20%
• Combination Drug 20%

Keyphrases

• Tezacaftor 100%